NASDAQ:SEEL

Seelos Therapeutics (SEEL) News Today

$0.19

-0.12 (-38.71%)

(As of 09/21/2023 ET)

Compare

Today's Range: $0.19
▼
$0.24
50-Day Range: $0.19
▼
$1.64
52-Week Range: $0.19
▼
$1.66

Volume: 33.60 million shs
Average Volume: 1.15 million shs
Market Capitalization: $24.30 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.33

Source

Source	Headline
	Why Is Seelos Therapeutics (SEEL) Stock Down 25% Today? investorplace.com - September 21 at 1:02 PM
	Seelos Therapeutics Shares Slide Premarket on SLS-002 Study Shortfall >SEEL marketwatch.com - September 20 at 7:43 PM
	Why Is Depression Focused Seelos Therapeutics Stock Plunging Today? msn.com - September 20 at 2:43 PM
	Seelos Therapeutics Shares Plumb New Depths on Study Shortfall >SEEL marketwatch.com - September 20 at 2:43 PM
	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision msn.com - September 20 at 9:42 AM
	Seelos Therapeutics’ stock slides 36% after trial of treatment for suicidal ideation has too few patients to meet endpoint msn.com - September 20 at 9:42 AM
	Seelos Therapeutics: SLS-002 Phase II Study Fails To Meet Primary Endpoint On Limited Sample Size markets.businessinsider.com - September 20 at 9:42 AM
	Seelos tumbles 66% as depression drug fails after it recruits too few patients proactiveinvestors.com - September 20 at 9:42 AM
	Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide finance.yahoo.com - September 20 at 9:42 AM
	7 Biotech Stocks to Sell in September Before They Crash & Burn finance.yahoo.com - September 14 at 10:37 AM
	4 Analysts Have This to Say About Seelos Therapeutics markets.businessinsider.com - August 22 at 6:27 PM
	MAI Capital Management Has $641,000 Stock Holdings in Seelos Therapeutics, Inc. (NASDAQ:SEEL) marketbeat.com - August 22 at 6:41 AM
	Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Seelos Therapeutics, Inc. (NASDAQ:SEEL) marketbeat.com - August 18 at 4:24 AM
	Cantor Fitzgerald Reiterates Seelos Therapeutics (SEEL) Overweight Recommendation msn.com - August 16 at 2:25 AM
	Seelos Therapeutics Provides Second Quarter 2023 Clinical Update finance.yahoo.com - August 14 at 6:03 PM
	Seelos Therapeutics' (NASDAQ:SEEL) investors will be pleased with their decent 52% return over the last year finance.yahoo.com - August 13 at 3:53 PM
	Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More markets.businessinsider.com - August 3 at 12:25 PM
	Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial markets.businessinsider.com - July 28 at 5:08 PM
	Financialnewsmedia.com: Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031 finanznachrichten.de - July 28 at 12:06 PM
	SEEL - Seelos Therapeutics, Inc. nz.finance.yahoo.com - July 18 at 10:31 AM
	Seelos Therapeutics (NASDAQ: SEEL) fool.com - July 15 at 2:08 AM
	Seelos: 2 Catalysts Before End Of 2023 Make This A Must Watch msn.com - July 12 at 11:00 PM
	Congressional psychedelic therapy caucus applauds FDA draft guidance msn.com - July 6 at 1:41 PM
	President Biden is ‘very open-minded’ about psychedelics, younger brother says msn.com - June 29 at 5:53 PM
	Psychedelic Therapeutics Market Grow at a CAGR 14.92 % from 2023 to 2031 \| Exclusive InsightAce Report finance.yahoo.com - June 27 at 3:33 PM
	Benchmark Co. Keeps Their Buy Rating on Seelos Therapeutics (SEEL) markets.businessinsider.com - June 25 at 10:34 PM
	Benchmark Reiterates Speculative Buy on Seelos Therapeutics, Maintains $4 Price Target benzinga.com - June 23 at 2:18 PM
	Cantor Fitzgerald Keeps Their Buy Rating on Seelos Therapeutics (SEEL) markets.businessinsider.com - June 23 at 2:18 PM
	Analyst Ratings for Seelos Therapeutics markets.businessinsider.com - June 23 at 2:18 PM
	Seelos Therapeutics Shares Rise 13% After Enrollment Closes for SLS-002 marketwatch.com - June 22 at 1:52 PM
	Seelos Therapeutics Announces the Close of Enrollment of its Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in Adults with Major Depressive Disorder (MDD) finance.yahoo.com - June 22 at 1:52 PM
	Mirae Asset Global Investments Co. Ltd. Sells 528,151 Shares of Seelos Therapeutics, Inc. (NASDAQ:SEEL) marketbeat.com - May 31 at 5:53 AM
	Seelos Therapeutics to Participate in Two Upcoming Healthcare Conferences finance.yahoo.com - May 22 at 8:37 AM
	Brokers Set Expectations for Seelos Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:SEEL) marketbeat.com - May 19 at 8:21 AM
	BTIG Maintains Seelos Therapeutics (SEEL) Buy Recommendation msn.com - May 16 at 10:04 PM
	Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History msn.com - May 16 at 10:04 PM
	Cantor Fitzgerald Maintains Seelos Therapeutics (SEEL) Overweight Recommendation msn.com - May 16 at 5:04 PM
	Seelos Therapeutics, Inc.: Seelos Therapeutics Provides Clinical Update and Reports First Quarter 2023 Financial Results finanznachrichten.de - May 15 at 1:24 PM
	Seelos Therapeutics, Inc Q1 Loss decreases, but misses estimates markets.businessinsider.com - May 15 at 1:24 PM
	Seelos Therapeutics GAAP EPS of -$0.12 misses by $0.02, revenue of $0.81M msn.com - May 15 at 1:24 PM
	BTIG Reaffirms Their Buy Rating on Seelos Therapeutics (SEEL) markets.businessinsider.com - May 15 at 8:23 AM
	Seelos Therapeutics Provides Clinical Update and Reports First Quarter 2023 Financial Results finance.yahoo.com - May 15 at 8:23 AM
	2030, Psychedelic Drugs Market: Trend & Outlook marketwatch.com - May 13 at 6:31 PM
	Seelos Therapeutics to Present a Poster on SLS-009 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting finance.yahoo.com - May 5 at 8:57 AM
	ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today msn.com - April 14 at 8:40 PM
	Unusual Call Option Trade in Seelos Therapeutics (SEEL) Worth $17.57K msn.com - April 6 at 8:46 PM
	Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis (ALS) Patient with SLS-005 in an Expanded Access Program finance.yahoo.com - April 4 at 12:49 PM
	BTIG Remains a Buy on Seelos Therapeutics (SEEL) markets.businessinsider.com - March 31 at 7:45 AM
	Psychedelic Medicine Market research Report with Analysis 2023 To 2030 marketwatch.com - March 30 at 12:56 PM
	Psychedelic Drugs Market Analysis, Industry Report, Trends 2029 marketwatch.com - March 30 at 7:56 AM

Get Seelos Therapeutics News Delivered to You Automatically

SEEL Media Mentions By Week

SEEL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SEEL
News Sentiment
▼
-0.74

0.53
▲
Average
Medical
News Sentiment

SEEL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SEEL Articles
This Week
▼
12

1
▲
SEEL Articles
Average Week

Get Seelos Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:SEEL) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Seelos Therapeutics (SEEL) News Today

SEEL Media Mentions By Week

SEEL Media Sentiment

SEEL News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info